litlas
ログインアカウント作成

Philippe Armand

1997–2025 年に発表

171
論文数
32,566
被引用数
90
h 指数
169
i10 指数

被引用数

Philippe Armand の年別被引用数1997 年: 被引用 1 件1998 年: 被引用 8 件1999 年: 被引用 19 件2000 年: 被引用 10 件2001 年: 被引用 30 件2002 年: 被引用 4 件2003 年: 被引用 12 件2004 年: 被引用 9 件2005 年: 被引用 18 件2006 年: 被引用 17 件2007 年: 被引用 20 件2008 年: 被引用 32 件2009 年: 被引用 39 件2010 年: 被引用 44 件2011 年: 被引用 44 件2012 年: 被引用 70 件2013 年: 被引用 100 件2014 年: 被引用 147 件2015 年: 被引用 307 件2016 年: 被引用 389 件2017 年: 被引用 539 件2018 年: 被引用 511 件2019 年: 被引用 1,581 件2020 年: 被引用 1,879 件2021 年: 被引用 1,845 件2022 年: 被引用 1,149 件2023 年: 被引用 911 件2024 年: 被引用 1,330 件2025 年: 被引用 593 件2026 年: 被引用 7 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,908 件、この内訳の 28.8%中国: 引用元論文 1,277 件、この内訳の 9.4%ドイツ: 引用元論文 859 件、この内訳の 6.3%イタリア: 引用元論文 776 件、この内訳の 5.7%フランス: 引用元論文 754 件、この内訳の 5.6%イギリス: 引用元論文 708 件、この内訳の 5.2%スペイン: 引用元論文 495 件、この内訳の 3.7%日本: 引用元論文 457 件、この内訳の 3.4%カナダ: 引用元論文 437 件、この内訳の 3.2%オランダ: 引用元論文 358 件、この内訳の 2.6%オーストラリア: 引用元論文 336 件、この内訳の 2.5%スイス: 引用元論文 316 件、この内訳の 2.3%
0%28.8%その他 21.3%

機関

分野

  • Medicine78.2%
  • Immunology and Microbiology11.4%
  • Biochemistry, Genetics and Molecular Biology8.7%
  • Engineering0.4%
  • Materials Science0.3%
  • Neuroscience0.2%
  • その他0.8%

トピック

  • Cancer Immunotherapy and Biomarkers9.4%
  • CAR-T cell therapy research8.3%
  • Immune Cell Function and Interaction6.8%
  • Lymphoma Diagnosis and Treatment6.4%
  • Hematopoietic Stem Cell Transplantation5.1%
  • Acute Myeloid Leukemia Research3.6%
  • その他60.4%

共著者

全論文

検索で開く
  1. PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma

    著者: Stephen M. Ansell, Alexander M. Lesokhin, Ivan Borrello, Ahmad Halwani, Emma C. Scott, Martin Gutierrez, Stephen J. Schuster, Michael Millenson, Deepika Cattry, Gordon J. Freeman, Scott J. Rodig, Bjoern Chapuy, Azra H. Ligon, Lili Zhu, Joseph F. Grosso, Su Young Kim, John M. Timmerman, Margaret A. Shipp, Philippe Armand - New England Journal of Medicine 2014 被引用: 3,547

  2. Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology

    著者: John A. Thompson, Bryan J. Schneider, Julie R. Brahmer, Amaka Achufusi, Philippe Armand, Meghan Berkenstock, Shailender Bhatia, Lihua E. Budde, Saurin Chokshi, Marianne Davies, Amro Elshoury, Yaron Gesthalter, Aparna Hegde, Michael D. Jain, Benjamin H. Kaffenberger, Melissa G. Lechner, Tianhong Li, Alissa Marr, Suzanne McGettigan, Jordan P. McPherson, Theresa Medina, Nisha Mohindra, Anthony J. Olszanski, Olalekan O. Oluwole, Sandip Pravin Patel, Pradnya D. Patil, Sunil Reddy, Mabel Ryder, Bianca Santomasso, Scott Shofer, Jeffrey A. Sosman, Yinghong Wang, Vlad G. Zaha, Megan Lyons, Mary A. Dwyer, Lisa Hang - Journal of the National Comprehensive Cancer Network 2022 被引用: 418

  3. Atorvastatin for Anthracycline-Associated Cardiac Dysfunction

    著者: Tomas G. Neilan, Thiago Quinaglia, Takeshi Onoue, Syed Mahmood, Zsófia D. Drobni, Hannah Gilman, Amanda M. Smith, Julius C. Heemelaar, Priya Brahmbhatt, Jor Sam Ho, Supraja Sama, Jakub Svoboda, Donna Neuberg, Jeremy S. Abramson, Ephraim P. Hochberg, Jefferey A. Barnes, Philippe Armand, Eric D. Jacobsen, Caron A. Jacobson, Austin I. Kim, Jacob D. Soumerai, Yuchi Han, Robb S. Friedman, Ann S. LaCasce, Bonnie Ky, D. L. Landsburg, Sunita D. Nasta, Raymond Y. Kwong, Michael Jerosch‐Herold, Robert Redd, Lanqi Hua, James L. Januzzi, Aarti Asnani, Negareh Mousavi, Marielle Scherrer‐Crosbie - JAMA 2023 被引用: 186

  4. NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020

    著者: John A. Thompson, Bryan J. Schneider, Julie R. Brahmer, Stephanie Andrews, Philippe Armand, Shailender Bhatia, Lihua E. Budde, Luciano J. Costa, Marianne Davies, David Dunnington, Marc S. Ernstoff, Matthew J. Frigault, Benjamin H. Kaffenberger, Matthew A. Lunning, Suzanne McGettigan, Jordan P. McPherson, Nisha Mohindra, Jarushka Naidoo, Anthony J. Olszanski, Olalekan O. Oluwole, Sandip Pravin Patel, Nathan A. Pennell, Sunil Reddy, Mabel Ryder, Bianca Santomasso, Scott Shofer, Jeffrey A. Sosman, Yinghong Wang, Ryan Weight, Alyse Johnson-Chilla, Griselda Zuccarino-Catania, Anita M. Engh - Journal of the National Comprehensive Cancer Network 2020 被引用: 486

  5. Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma

    著者: Christopher J. Gibson, R. Coleman Lindsley, Vatche Tchekmedyian, Brenton G. Mar, Jiantao Shi, Siddhartha Jaiswal, Alysia Bosworth, Liton Francisco, Jianbo He, Anita Bansal, Elizabeth A. Morgan, Ann S. LaCasce, Arnold S. Freedman, David C. Fisher, Eric D. Jacobsen, Philippe Armand, Edwin P. Alyea, John Koreth, Vincent T. Ho, Robert J. Soiffer, Joseph H. Antin, Jerome Ritz, Sarah Nikiforow, Stephen J. Forman, Franziska Michor, Donna Neuberg, Ravi Bhatia, Ravi Bhatia, Benjamin L. Ebert - Journal of Clinical Oncology 2017 被引用: 470

  6. Sodium-Glucose Co-Transporter-2 Inhibitors and Cardiac Outcomes Among Patients Treated With Anthracyclines

    著者: Carlos A. Gongora, Zsófia D. Drobni, Thiago Quinaglia Araujo Costa Silva, Amna Zafar, Jingyi Gong, Daniel A. Zlotoff, Hannah Gilman, Sarah Hartmann, Supraja Sama, Sofia Nikolaidou, Giselle Alexandra Suero‐Abreu, Eric N. Jacobsen, Jeremy S. Abramson, Ephraim P. Hochberg, J. R. Barnes, Philippe Armand, Paaladinesh Thavendiranathan, Anju Nohria, Tomas G. Neilan - JACC Heart Failure 2022 被引用: 155

  7. Axicabtagene Ciloleucel in the Non-Trial Setting: Outcomes and Correlates of Response, Resistance, and Toxicity

    著者: Caron A. Jacobson, Bradley D. Hunter, Robert Redd, Scott J. Rodig, Pei-Hsuan Chen, Kyle Wright, Mikel Lipschitz, Jerome Ritz, Yusuke Kamihara, Philippe Armand, Sarah Nikiforow, Michael Rogalski, Joseph Maakaron, Samantha Jaglowski, Marcela V. Maus, Yi‐Bin Chen, Jeremy S. Abramson, Justin Kline, Elizabeth Budde, Alex F. Herrera, Matthew Mei, Jonathon B. Cohen, Stephen D. Smith, David G. Maloney, Ajay K. Gopal, Matthew J. Frigault, Utkarsh Acharya - Journal of Clinical Oncology 2020 被引用: 345

  8. Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy

    著者: Jennifer L. Crombie, Tara Graff, Lorenzo Falchi, Yasmin Karimi, Rajat Bannerji, Loretta J. Nastoupil, Catherine Thiéblemont, Rénata Ursu, Nancy L. Bartlett, Victoria Nachar, J. Weiss, Jane Osterson, Krish Patel, Joshua Brody, Jeremy S. Abramson, Matthew A. Lunning, Nirav N. Shah, Ayed O. Ayed, Manali Kamdar, Benjamin M. Parsons, Paolo F. Caimi, Ian W. Flinn, Alex F. Herrera, Jeffrey P. Sharman, Marshall McKenna, Philippe Armand, Brad S. Kahl, Sonali M. Smith, Andrew D. Zelenetz, Lihua E. Budde, Martin Hutchings, Tycel Phillips, Michael Dickinson - Blood 2024 被引用: 131

  9. Management of Immunotherapy-Related Toxicities, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology

    著者: John A. Thompson, Bryan J. Schneider, Julie R. Brahmer, Stephanie Andrews, Philippe Armand, Shailender Bhatia, Lihua E. Budde, Luciano J. Costa, Marianne Davies, David Dunnington, Marc S. Ernstoff, Matthew J. Frigault, Brianna Hoffner, Christopher Hoimes, Mario E. Lacouture, Frederick L. Locke, Matthew A. Lunning, Nisha Mohindra, Jarushka Naidoo, Anthony J. Olszanski, Olalekan O. Oluwole, Sandip Pravin Patel, Sunil Reddy, Mabel Ryder, Bianca Santomasso, Scott Shofer, Jeffrey A. Sosman, Momen M. Wahidi, Yinghong Wang, Alyse Johnson-Chilla, Jillian L. Scavone - Journal of the National Comprehensive Cancer Network 2019 被引用: 560

  10. PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome

    著者: Margaretha G.M. Roemer, Ranjana H. Advani, Azra H. Ligon, Yasodha Natkunam, Robert Redd, Heather Homer, Courtney Connelly, Heather H. Sun, Sarah E. Daadi, Gordon J. Freeman, Philippe Armand, Bjoern Chapuy, Daphne de Jong, Richard T. Hoppe, Donna Neuberg, Scott J. Rodig, Margaret A. Shipp - Journal of Clinical Oncology 2016 被引用: 803

  11. Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial

    著者: Philippe Armand, Andreas Engert, Anas Younes, Michelle A. Fanale, Armando Santoro, Pier Luigi Zinzani, John M. Timmerman, Graham P. Collins, Radhakrishnan Ramchandren, Jonathon B. Cohen, Jan Paul de Boer, John Kuruvilla, Kerry J. Savage, Marek Trněný, Margaret A. Shipp, Kazunobu Kato, Anne Sumbul, Benedetto Farsaci, Stephen M. Ansell - Journal of Clinical Oncology 2018 被引用: 754

  12. Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease

    著者: John Koreth, Ken‐ichi Matsuoka, Haesook T. Kim, Sean M. McDonough, Bhavjot Bindra, Edwin P. Alyea, Philippe Armand, Corey Cutler, Vincent T. Ho, Nathaniel S. Treister, Don C. Bienfang, Sashank Prasad, Dmitrios Tzachanis, Robin Joyce, David Avigan, Joseph H. Antin, Jerome Ritz, Robert J. Soiffer - New England Journal of Medicine 2011 被引用: 1,117

  13. Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study

    著者: Alexander M. Lesokhin, Stephen M. Ansell, Philippe Armand, Emma Scott, Ahmad Halwani, Martin Gutierrez, Michael Millenson, Adam D. Cohen, Stephen J. Schuster, Daniel Lebovic, Madhav V. Dhodapkar, David Avigan, Bjoern Chapuy, Azra H. Ligon, Gordon J. Freeman, Scott J. Rodig, Deepika Cattry, Lili Zhu, Joseph F. Grosso, M. Brigid Garelik, Margaret A. Shipp, Ivan Borrello, John M. Timmerman - Journal of Clinical Oncology 2016 被引用: 1,011

  14. Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma

    著者: Robert Chen, Pier Luigi Zinzani, Michelle A. Fanale, Philippe Armand, Nathalie A. Johnson, Pauline Brice, John Radford, Vincent Ribrag, Daniel Molin, Theodoros P. Vassilakopoulos, Akihiro Tomita, Bastian von Tresckow, Margaret A. Shipp, Yinghua Zhang, Alejandro D. Ricart, Arun Balakumaran, Craig H. Moskowitz, for the KEYNOTE-087 - Journal of Clinical Oncology 2017 被引用: 985

  15. Ipilimumab for Patients with Relapse after Allogeneic Transplantation

    著者: Matthew S. Davids, Haesook T. Kim, Pavan Bachireddy, Caitlin Costello, Rebecca Liguori, Alexandra Savell, Alexander Lukez, David Avigan, Yi‐Bin Chen, Peter A. McSweeney, Nicole R. LeBoeuf, Michael S. Rooney, Michaela Bowden, Chensheng W. Zhou, Scott R. Granter, Jason L. Hornick, Scott J. Rodig, Masahiro Hirakawa, Mariano Severgnini, F. Stephen Hodi, Catherine J. Wu, Vincent T. Ho, Corey Cutler, John Koreth, Edwin P. Alyea, Joseph H. Antin, Philippe Armand, Howard Streicher, Edward D. Ball, Jerome Ritz, Asad Bashey, Robert J. Soiffer - New England Journal of Medicine 2016 被引用: 594

  16. Indolent CD4+ CAR T-Cell Lymphoma after Cilta-cel CAR T-Cell Therapy

    著者: Metin Özdemirli, Thomas Loughney, Emre Deniz, Joeffrey Chahine, Maher Albitar, Stefania Pittaluga, Sam Sadigh, Philippe Armand, Aykut Uren, Kenneth C. Anderson - New England Journal of Medicine 2024 被引用: 90

  17. Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma

    著者: Margaretha G.M. Roemer, Robert Redd, Fathima Zumla Cader, Christine J. Pak, Sara Abdelrahman, Jing Ouyang, Stephanie Sasse, Anas Younes, Michelle A. Fanale, Armando Santoro, Pier Luigi Zinzani, John M. Timmerman, Graham P. Collins, Radhakrishnan Ramchandren, Jonathon B. Cohen, Jan Paul de Boer, John Kuruvilla, Kerry J. Savage, Marek Trněný, Stephen M. Ansell, Kazunobu Kato, Benedetto Farsaci, Anne Sumbul, Philippe Armand, Donna Neuberg, Geraldine S. Pinkus, Azra H. Ligon, Scott J. Rodig, Margaret A. Shipp - Journal of Clinical Oncology 2018 被引用: 367

  18. Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation

    著者: Philippe Armand, Haesook T. Kim, Brent R. Logan, Zhiwei Wang, Edwin P. Alyea, Matt Kalaycio, Richard T. Maziarz, Joseph H. Antin, Robert J. Soiffer, Daniel J. Weisdorf, J. Douglas Rizzo, Mary M. Horowitz, Wael Saber - Blood 2014 被引用: 942

  19. Refinement of the Lugano Classification lymphoma response criteria in the era of immunomodulatory therapy

    著者: Bruce D. Cheson, Stephen M. Ansell, Larry Schwartz, Leo I. Gordon, Ranjana H. Advani, Heather A. Jacene, Axel Hoos, Sally F. Barrington, Philippe Armand - Blood 2016 被引用: 506

  20. PD-1 blockade with nivolumab in relapsed/refractory primary central nervous system and testicular lymphoma

    著者: Lakshmi Nayak, Fábio M. Iwamoto, Ann S. LaCasce, Srinivasan Mukundan, Margaretha G.M. Roemer, Bjoern Chapuy, Philippe Armand, Scott J. Rodig, Margaret A. Shipp - Blood 2017 被引用: 459

  21. Nivolumab for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Patients Ineligible for or Having Failed Autologous Transplantation: A Single-Arm, Phase II Study

    著者: Stephen M. Ansell, Monique C. Minnema, Peter Johnson, John M. Timmerman, Philippe Armand, Margaret A. Shipp, Scott J. Rodig, Azra H. Ligon, Margaretha G.M. Roemer, Nishitha Reddy, Jonathon B. Cohen, Sarit Assouline, Michelle Poon, Manish Sharma, Kazunobu Kato, Selda Samakoglu, Anne Sumbul, Andrew Grigg - Journal of Clinical Oncology 2019 被引用: 363

  22. A phase 1b study of AFM13 in combination with pembrolizumab in patients with relapsed or refractory Hodgkin lymphoma

    著者: Nancy L. Bartlett, Alex F. Herrera, Eva Domingo‐Doménech, Amitkumar Mehta, Andres Forero‐Torres, Ramón García‐Sánz, Philippe Armand, Sumana Devata, Antonia Rodríguez Izquierdo, Izidore S. Lossos, Craig B. Reeder, Taimur Sher, Robert Chen, Sylvia E. Schwarz, Leila Alland, András Strassz, Kim Prier, Cassandra Choe-Juliak, Stephen M. Ansell - Blood 2020 被引用: 151

  23. Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma

    著者: Matthew J. Frigault, Jörg Dietrich, Maria Martinez‐Lage, Mark B. Leick, Bryan D. Choi, Zachariah DeFilipp, Yi‐Bin Chen, Jeremy S. Abramson, Jennifer L. Crombie, Philippe Armand, Lakshmi Nayak, Chris Panzini, Lauren S. Riley, Kathleen Gallagher, Marcela V. Maus - Blood 2019 被引用: 237

  24. Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial

    著者: Anas Younes, Armando Santoro, Margaret A. Shipp, Pier Luigi Zinzani, John M. Timmerman, Stephen M. Ansell, Philippe Armand, Michelle A. Fanale, Voravit Ratanatharathorn, John Kuruvilla, Jonathon B. Cohen, Graham P. Collins, Kerry J. Savage, Marek Trněný, Kazunobu Kato, Benedetto Farsaci, Susan Parker, Scott J. Rodig, Margaretha G.M. Roemer, Azra H. Ligon, Andreas Engert - The Lancet Oncology 2016 被引用: 924